Exemestane (FCE 24304), A new steroidal aromatase inhibitor
- 1 September 1992
- journal article
- clinical trial
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 43 (1-3) , 137-143
- https://doi.org/10.1016/0960-0760(92)90198-r
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Comparison of the effects of the irreversible aromatase inhibitor exemestane with atamestane and MDL 18962 in rats with DMBA-induced mammary tumoursEuropean Journal of Cancer and Clinical Oncology, 1991
- Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedioneCancer Chemotherapy and Pharmacology, 1990
- Phase I study in healthy male volunteers with the non-steroidal aromatase inhibitor CGS 20267European Journal of Cancer and Clinical Oncology, 1990
- R 76713, a new specific non-steroidal aromatase inhibitorThe Journal of Steroid Biochemistry and Molecular Biology, 1989
- Aromatase inhibition by R 76713: Experimental and clinical pharmacologyJournal of Steroid Biochemistry, 1989
- 6-Methylenandrosta-1,4-diene-3,17-dione (FCE 24304): A new irreversible aromatase inhibitorJournal of Steroid Biochemistry, 1988
- Aromatase inhibitors and benign prostatic hyperplasiaJournal of Steroid Biochemistry, 1986
- Metabolism of the aromatase inhibitor 4-hydroxyandrostenedione in vivo. Identification of the glucuronide as a major urinary metabolite in patients and biliary metabolite in the ratThe Journal of Steroid Biochemistry and Molecular Biology, 1986
- 1-methyl-1,4-androstadiene-3,17-dione (SH 489): Characterization of an irreversible inhibitor of estrogen biosynthesisJournal of Steroid Biochemistry, 1986
- 28 In vivo testing of irreversible aromatase inhibitors in the ratJournal of Steroid Biochemistry, 1985